Literature DB >> 1422398

Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing.

M A de Belder1, N J Linker, S Jones, A J Camm, D E Ward.   

Abstract

OBJECTIVE: To compare present pacing practice with the recommendations recently published by the British Pacing and Electrophysiology Group and to assess the increase in annual budget required to implement these recommendations in a regional cardiothoracic unit.
DESIGN: Retrospective analysis of pacemaker implantation for 1991 with calculation of the costs required to implement the group's recommendations based on average 1991 costs of the types of pacing generators and electrode leads used.
SETTING: Regional cardiothoracic unit for South West Thames Health Authority. PATIENTS: 433 consecutive patients receiving permanent pacemaker generators: 76 (18%) with sinus node disease; 270 (62%) with atrioventricular block; 25 (6%) with both sinus node disease and atrioventricular block; 59 (14%) with chronic atrial fibrillation and atrioventricular block; and 3 (1%) with carotid sinus or malignant vasovagal syndromes.
RESULTS: Only 102 (24%) patients received pacemaker generators recommended by the British Pacing and Electrophysiology Group; however, 355 (82%) patients were older than 65 years, and 264 (61%) were aged 75 or over. The cost of hardware for pacing was 462,885 pounds. Using generators as recommended would have cost 810,525 pounds for "optimal" systems (an increase of 75%) and 710,750 pounds for "alternative" systems (an increase of 54%). These increases would have been considerably reduced by limiting the use of sophisticated pacing to younger patients (aged under 75). Further savings could be made by using the least expensive pacing models available.
CONCLUSIONS: Implementing these recommendations should reduce morbidity related to bradyarrhythmia but will lead to major increases in pacing costs. Age and patients' expected activity may be used to select simple pacing systems and thus to contain cost. More research is needed to determine which patient groups will benefit most from complex pacing systems.

Entities:  

Mesh:

Year:  1992        PMID: 1422398      PMCID: PMC1883084          DOI: 10.1136/bmj.305.6858.861

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  6 in total

1.  Indications for pacing.

Authors:  A Ahsan
Journal:  Lancet       Date:  1992-01-04       Impact factor: 79.321

Review 2.  The pacemaker syndrome: old and new causes.

Authors:  H Schüller; J Brandt
Journal:  Clin Cardiol       Date:  1991-04       Impact factor: 2.882

3.  Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups.

Authors:  Y Sasaki; M Shimotori; K Akahane; H Yonekura; K Hirano; R Endoh; S Koike; S Kawa; S Furuta; T Homma
Journal:  Pacing Clin Electrophysiol       Date:  1988-11       Impact factor: 1.976

4.  The incidence of malignant vasovagal syndrome in patients with recurrent syncope.

Authors:  A Fitzpatrick; G Theodorakis; P Vardas; R A Kenny; C M Travill; A Ingram; R Sutton
Journal:  Eur Heart J       Date:  1991-03       Impact factor: 29.983

5.  Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing.

Authors:  R Zanini; A I Facchinetti; G Gallo; L Cazzamalli; L Bonandi; L Dei Cas
Journal:  Pacing Clin Electrophysiol       Date:  1990-12       Impact factor: 1.976

6.  Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality.

Authors:  M Rosenqvist; J Brandt; H Schüller
Journal:  Am Heart J       Date:  1988-07       Impact factor: 4.749

  6 in total
  15 in total

1.  A study comparing VVI and DDI pacing in elderly patients with carotid sinus syndrome.

Authors:  S J McIntosh; J Lawson; R S Bexton; R G Gold; M M Tynan; R A Kenny
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

2.  Recommendations for pacing.

Authors:  A P Banning; P G Avery; L A McGurk; A G Fraser; M Buchalter
Journal:  BMJ       Date:  1992-12-05

3.  Recommendations for pacing.

Authors:  R Sutton; J Perrins; M Clarke; S M Cobbe; R G Charles
Journal:  BMJ       Date:  1992-12-05

Review 4.  Coronary artery disease, valvular heart disease, bradycardia, and heart failure.

Authors:  E Smith; H Powell; I R Hastie
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

5.  The United Kingdom pacing and cardiovascular events (UKPACE) trial. United Kingdom Pacing and Cardiovascular Events.

Authors:  W D Toff; J D Skehan; D P De Bono; A J Camm
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

Review 6.  Recent advances in cardiology.

Authors:  C S Lawson; D J Coltart
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

7.  Prevalence of diabetes in elderly patients with pacemakers.

Authors:  J T Lear; I G Lawrence; A C Burden
Journal:  Postgrad Med J       Date:  1995-12       Impact factor: 2.401

8.  Who needs dual chamber pacing?

Authors:  M C Petch
Journal:  BMJ       Date:  1993-07-24

9.  Issues in cardiac pacing: can agism be justified?

Authors:  G E Payne; J D Skehan
Journal:  Br Heart J       Date:  1994-08

Review 10.  Permanent pacemakers and the elderly: concerns, costs and benefits.

Authors:  J M McComb; R S Bexton
Journal:  Br Heart J       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.